InsidersTradesSigma
Track the Transcode Therapeutics, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Transcode Therapeutics, Inc. has published 10 public disclosures. Market capitalisation: €8m. The latest transaction was filed on 5 August 2026 (C). Among the most active insiders: Dudley Robert Michael. Every trade is free.
10
Insider Decl.
n/a
Thresholds
€269,443
8 ops.
Buy Volume
n/a
n/a
Sell Volume
58Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 August 2026
Declarations10 total
98,000 shares@ US$0.5120.5% of flowCommon StockSEC:0001104659-23-105924:0
Canonical exit: 27 Dec 2023 (T+90)
49,350 shares@ US$0.5162.3% of flowCommon StockSEC:0001104659-23-105925:0
Canonical exit: 27 Dec 2023 (T+90)
6,607 shares@ US$2.54986.7% of flowCommon StockSEC:0001104659-23-073872:0
Canonical exit: 18 Sept 2023 (T+90)
19,000 shares@ US$2.7621.0% of flowCommon StockSEC:0001104659-23-071204:0
Canonical exit: 7 Sept 2023 (T+90)
19,000 shares@ US$2.7621.0% of flowCommon StockSEC:0001104659-23-070804:0
Canonical exit: 7 Sept 2023 (T+90)
20,000 shares@ US$1.1510.0% of flowCommon StockSEC:0001104659-22-100931:0
Canonical exit: 13 Dec 2022 (T+90)
12,000 shares@ US$1.270.24% mcap100.0% of flowCommon StockSEC:0001104659-22-072369:0
Canonical exit: 14 Sept 2022 (T+90)
28,000 shares@ US$1.84440.80% mcap100.0% of flowCommon StockSEC:0001104659-22-067099:0
Canonical exit: 25 Aug 2022 (T+90)
10 of 10 declarations
关于 Transcode Therapeutics, Inc.
Transcode Therapeutics, Inc. 是一家专注于开发创新癌症治疗方法的公司。它专门研究基于RNA的解决方案，以改善患者预后。